To help you understand what is going on in the healthcare industry and what we expect to happen in the future, our highly experienced Kiplinger Letter team will keep you abreast of the latest developments and forecasts (Get a free issue of The Kiplinger Letter or subscribe). You'll get all the latest news first by subscribing, but we will publish many (but not all) of the forecasts a few days afterward online. Here’s the latest...
If you’re worried about healthcare costs, for either your business or your personal situation, a raft of money-saving shifts are coming to the healthcare sector, promising to ease the strain on overburdened hospitals, while reducing expenses for patients and employers, who foot a lot of the bill.
One key to controlling future medical costs: moving more care to outpatient settings, meaning the patient goes home after a procedure instead of spending one or more nights recuperating in the hospital. It’s probably what most people want to begin with, and it can save a bundle vs a long stay in the hospital, especially with hospitals short-staffed.
From just $107.88 $24.99 for Kiplinger Personal Finance
Become a smarter, better informed investor. Subscribe from just $107.88 $24.99, plus get up to 4 Special Issues
Sign up for Kiplinger’s Free Newsletters
Profit and prosper with the best of expert advice on investing, taxes, retirement, personal finance and more - straight to your e-mail.
Profit and prosper with the best of expert advice - straight to your e-mail.
Outpatient care will grow 18% by 2033, well ahead of the expected 2% rise in inpatient care. More surgeries will become outpatient as surgical techniques and post-surgery treatment are refined, reducing the need for hospitalization. More joint replacements, for instance, with patients going home to begin recovery and physical therapy.
Other conditions for which treatment will be offered much more often in outpatient settings are dementia, cancer, cardiovascular problems like chronic heart failure, diabetes and lung disease. Telemedicine is also poised to mushroom after catching on in the pandemic. A decade from now, remote visits will account for 26% of all appointments with doctors.
Advances in medical technology also promise to curb healthcare costs. Laparoscopic and other “keyhole” surgeries are being used more widely, enabling faster, less expensive recoveries. The growing use of surgical robots and improvements in robotics are expanding the array of minimally invasive surgeries.
Cheaper alternatives to blockbuster drugs should provide more cost relief. Biosimilars, which closely mimic original drugs, are proliferating. For example, a biosimilar version of AbbVie’s blockbuster arthritis treatment Humira hit the market earlier this year at a lower cost. Other biosimilars targeting popular drugs are coming. Eventually, they could lower prescription costs similarly to how generics have done.
The downside of better medical treatments: more people tend to use them, driving up overall health spending. The growing array of obesity drugs, for example, could improve the lives of millions and cut medical costs associated with obesity. But they figure to be very popular and will fuel a burst of additional drug spending.
There’s more competition coming to the healthcare market, too. Basic care is especially ripe for cost containment as new players offer inexpensive clinics to treat routine, nonemergency issues. Amazon Clinic, for instance, is now operating in all 50 states, offering low, fixed prices for 30 common conditions. Walmart Health operates in five states and treats a range of medical, behavioral and dental issues
This forecast first appeared in The Kiplinger Letter, which has been running since 1923 and is a collection of concise weekly forecasts on business and economic trends, as well as what to expect from Washington, to help you understand what’s coming up to make the most of your investments and your money. Subscribe to The Kiplinger Letter.
Related stories
-
I'm want to give my 3 grandkids $5K each for Christmas.You're comfortably retired and want to give your grandkids a big Christmas check, but their parents are worried they might spend it all. We ask the pros for help.
-
If You're Not Doing Roth Conversions, You Need to Read ThisRoth conversions and other Roth strategies can be complex, but don't dismiss these tax planning tools outright. They could really work for you and your heirs.
-
Could Traditional Retirement Expectations Be Killing Us?A retirement psychologist makes the case: A fulfilling retirement begins with a blueprint for living, rather than simply the accumulation of a large nest egg.
-
AI Appliances Aren’t Exciting Buyers…YetThe Kiplinger Letter Artificial intelligence is being embedded into all sorts of appliances. Now sellers need to get customers to care about AI-powered laundry.
-
What to Expect from the Global Economy in 2026The Kiplinger Letter Economic growth across the globe will be highly uneven, with some major economies accelerating while others hit the brakes.
-
The AI Boom Will Lift IT Spending Next YearThe Kiplinger Letter 2026 will be one of strongest years for the IT industry since the PC boom and early days of the Web in the mid-1990s.
-
Amid Mounting Uncertainty: Five Forecasts About AIThe Kiplinger Letter With the risk of overspending on AI data centers hotly debated, here are some forecasts about AI that we can make with some confidence.
-
Worried About an AI Bubble? Here’s What You Need to KnowThe Kiplinger Letter Though AI is a transformative technology, it’s worth paying attention to the rising economic and financial risks. Here’s some guidance to navigate AI’s future.
-
Will AI Videos Disrupt Social Media?The Kiplinger Letter With the introduction of OpenAI’s new AI social media app, Sora, the internet is about to be flooded with startling AI-generated videos.
-
What Services Are Open During the Government Shutdown?The Kiplinger Letter As the shutdown drags on, many basic federal services will increasingly be affected.
-
The Economy on a Knife's EdgeThe Letter GDP is growing, but employers have all but stopped hiring as they watch how the trade war plays out.
